Charles A Rowland Jr insider trades

Open-market stock purchases and sales by Charles A Rowland Jr, Director at Generation Bio Co, from SEC Form 4 filings since Jan 7, 2010.

Recent trades

DateStockTradeValue
Feb 9, 2026GBIO Generation Bio CoSold (not open market)—
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$11.6K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$195K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$988K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$399K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$119K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$121K
Feb 9, 2026GBIO Generation Bio CoSold (not open market)$199K
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Jan 2, 2026VKTX Viking Therapeutics, IncBought (not open market)—
Oct 27, 2025VKTX Viking Therapeutics, IncBought (not open market)$71.7K
Oct 27, 2025VKTX Viking Therapeutics, IncBought (not open market)$107K
Oct 27, 2025VKTX Viking Therapeutics, IncSold$2.1M
Oct 27, 2025VKTX Viking Therapeutics, IncBought (not open market)—
Oct 27, 2025VKTX Viking Therapeutics, IncBought (not open market)—

Companies traded

  • GBIO Generation Bio Co: 9 buys, last Feb 9, 2026
  • VKTX Viking Therapeutics, Inc: 1 buy, 2 sales, last Jan 2, 2026
  • ORTX Orchard Therapeutics plc: other filings, last Jan 24, 2024
  • NBRV Nabriva Therapeutics plc: 1 buy, 2 sales, last Aug 1, 2022
  • BPMC Blueprint Medicines Corp: 8 sales, last Jun 2, 2021
  • VTAE Vitae Pharmaceuticals, Inc: other filings, last Oct 25, 2016
  • BIND Dnib Unwind, Inc: other filings, last Aug 26, 2016
  • IDIX Idenix Pharmaceuticals Inc: other filings, last Aug 5, 2014
  • VPHM Viropharma Inc: 4 sales, last Jan 24, 2014

Get free alerts when Charles A Rowland Jr files a new trade →